Mental Health Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
- Healthcare IT
Mental health is a state of psychological well-being or an absence of any mental illness. It is a psychological level of an individual who functions properly at a satisfactory level of behavioral and emotional adjustment. Disturbance or imbalance in this mental state could give rise to mental illness or disorders. Mental illness can cause abnormal behavior and unusual thoughts and feelings for a certain period of time, which causes distress or emotional or physical impairment. Under the central nervous system therapeutics market, mental health segment accounted for the largest market share in 2016. It is expected to dominate the market in the next few years due to extensive research & development in the field and more therapeutic options for various mental diseases such as personality disorders and binge eating disorders.
The global mental health therapeutics markets can be segmented based on type, treatment, and region. In terms of disease type, the market can be categorized into anxiety disorders, mood disorders, substance abuse disorders, and others (insomnia, binge eating disorder). Based on treatment, the market can be classified into somatic, psychotherapeutic, and others. Somatic treatments includes drug therapy, medication, complementary & alternative medicine, and electroconvulsive therapy. Psychotherapeutic treatments involve cognitive behavioral therapy (CBT), interpersonal therapy, group discussion or family support therapy, marital psychotherapy, peer support, hypnotherapy, and behavior therapy techniques. Research suggests that severe and complex mental health disorders require a combination of drugs and psychotherapy rather than a single method of treatment. Other types of therapies include hospitalization, case management, self-help plan, and art therapy.
Major factors driving the growth of the mental health market include rising geriatric population, mental health reforms, government initiatives for improving mental health care services, and number of people seeking mental health support. On the other hand, low rate of adoption of mental health electronic health records (EHRs), data privacy concerns, and lack of psychiatrists and healthcare IT professionals are expected to restrain the growth of this market. The psychotherapeutic drug industry continues to struggle through conflicting issues that are directly or indirectly affecting competition. Some recent hurdles faced by competitors in the market include advertising restrictions, label changes, and negative perceptions about mental illness treatments; however, advancements in delivery techniques, education and awareness efforts, and effectiveness could boost market growth.
Geographically, the global mental health therapeutics market is divided into five regions: North America, Europe, Asia Pacific, Middle East & Africa, and Rest of the World. North America dominates the market with the U.S. accounting for a major market share. Nearly one in five (18.5%) Americans experiences mental health problems each year. In the U.S., in 2015, an estimated 9.8 million, which equated to nearly 4.8% of all adults (over 18 years of age) had serious mental disorders. Europe is considered as the second largest region in the psychotherapies market. Presence of multiple psychotherapy associations such as the United Kingdom Council for Psychotherapy, the British Psychoanalytic Council, and the British Association for Counselling and Psychotherapy drives the market growth. The market in Asia is expected to expand at the highest CAGR during the forecast period. This growth can be attributed to government initiatives, increasing demand for mental health services, and rising focus of major players on the markets such as India. Emerging markets such as India, China, and countries in the Middle East offer great opportunities for this market owing to changing lifestyle coupled with increasing psychological disease awareness among people.
Key players involved in the global mental health therapeutics markets are Pfizer, Inc., Forest Laboratories, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb Company, Wyeth, Teva Pharmaceutical Industries Ltd., and Biogen, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017